ATE343569T1 - Aromatische hydroxamsäurederivate, die sich als hdac inhibitoren eignen - Google Patents

Aromatische hydroxamsäurederivate, die sich als hdac inhibitoren eignen

Info

Publication number
ATE343569T1
ATE343569T1 AT02791436T AT02791436T ATE343569T1 AT E343569 T1 ATE343569 T1 AT E343569T1 AT 02791436 T AT02791436 T AT 02791436T AT 02791436 T AT02791436 T AT 02791436T AT E343569 T1 ATE343569 T1 AT E343569T1
Authority
AT
Austria
Prior art keywords
acid derivatives
hydroxamic acid
hdac inhibitors
derivatives suitable
aromatic hydroxamic
Prior art date
Application number
AT02791436T
Other languages
English (en)
Inventor
Ulrike Leser-Reiff
Tim Dr Sattelkau
Gerd Zimmermann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE343569T1 publication Critical patent/ATE343569T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
AT02791436T 2001-06-15 2002-06-13 Aromatische hydroxamsäurederivate, die sich als hdac inhibitoren eignen ATE343569T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01114496 2001-06-15

Publications (1)

Publication Number Publication Date
ATE343569T1 true ATE343569T1 (de) 2006-11-15

Family

ID=8177731

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02791436T ATE343569T1 (de) 2001-06-15 2002-06-13 Aromatische hydroxamsäurederivate, die sich als hdac inhibitoren eignen

Country Status (33)

Country Link
US (2) US6784173B2 (de)
EP (1) EP1401824B1 (de)
JP (1) JP4195377B2 (de)
KR (2) KR100910958B1 (de)
CN (1) CN1271066C (de)
AR (1) AR036055A1 (de)
AT (1) ATE343569T1 (de)
AU (1) AU2002355626B2 (de)
BG (1) BG108450A (de)
BR (1) BR0210424A (de)
CA (1) CA2449804A1 (de)
CO (1) CO5540280A2 (de)
CZ (1) CZ200425A3 (de)
DE (1) DE60215652T2 (de)
EC (1) ECSP034896A (de)
ES (1) ES2272800T3 (de)
GT (1) GT200200121A (de)
HK (1) HK1065787A1 (de)
HR (1) HRP20031019A2 (de)
HU (1) HUP0401233A3 (de)
IL (1) IL159097A0 (de)
MA (1) MA27041A1 (de)
MX (1) MXPA03011501A (de)
NO (1) NO20035555D0 (de)
NZ (1) NZ529874A (de)
PA (1) PA8548001A1 (de)
PE (1) PE20030086A1 (de)
PL (1) PL366729A1 (de)
RS (1) RS98203A (de)
RU (1) RU2289580C2 (de)
SK (1) SK172004A3 (de)
WO (1) WO2003011851A2 (de)
ZA (1) ZA200309260B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6822267B1 (en) * 1997-08-20 2004-11-23 Advantest Corporation Signal transmission circuit, CMOS semiconductor device, and circuit board
NZ534831A (en) 2002-03-13 2007-01-26 Janssen Pharmaceutica Nv Carbonylamino-derivatives having histone deacetylase (HDAC) inhibiting enzymatic activity
JP4725944B2 (ja) * 2002-03-13 2011-07-13 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒストンデアセチラーゼの阻害剤
EP1492534B1 (de) * 2002-04-03 2008-06-25 TopoTarget UK Limited Carbaminsäurederivate enthaltend eine piperazin verknüpfung als hdac-inhibitoren
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7098241B2 (en) * 2002-12-16 2006-08-29 Hoffmann-La Roche Inc. Thiophene hydroxamic acid derivatives
TW200424174A (en) * 2003-02-06 2004-11-16 Hoffmann La Roche New TP diamide
US7208491B2 (en) * 2003-02-07 2007-04-24 Hoffmann-La Roche Inc. N-monoacylated o-phenylenediamines
US7169801B2 (en) 2003-03-17 2007-01-30 Takeda San Diego, Inc. Histone deacetylase inhibitors
TW200424187A (en) * 2003-04-04 2004-11-16 Hoffmann La Roche New oxime derivatives and their use as pharmaceutically active agents
CA2542096A1 (en) * 2003-10-09 2005-04-21 Aton Pharma, Inc. Thiophene and benzothiophene hydroxamic acid derivatives
WO2005066151A2 (en) * 2003-12-19 2005-07-21 Takeda San Diego, Inc. Histone deacetylase inhibitors
WO2005065681A1 (en) * 2003-12-19 2005-07-21 Takeda San Diego, Inc. N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer
US7217723B2 (en) 2004-02-02 2007-05-15 Eisai Co., Ltd. Heterocyclic compound having oxime group
US7521473B2 (en) * 2004-02-25 2009-04-21 Wyeth Inhibitors of protein tyrosine phosphatase 1B
US20050203081A1 (en) * 2004-02-25 2005-09-15 Jinbo Lee Inhibitors of protein tyrosine phosphatase 1B
JP2008502627A (ja) * 2004-06-14 2008-01-31 エフ．ホフマン−ラ　ロシュ　アーゲー ヒドロキサム酸塩、その製造、および薬剤としての使用
WO2005121120A1 (en) * 2004-06-14 2005-12-22 F. Hoffmann-La Roche Ag Thiophene hydroxamic acid derivatives and their use as hdac inhibitors
US7396944B2 (en) * 2004-06-14 2008-07-08 Hoffmann-La Roche Inc. Thiophene derivatives, their manufacture and use as pharmaceutical agents
MX2007001120A (es) 2004-07-28 2007-03-15 Janssen Pharmaceutica Nv Derivados de indolil alquil sustituidos como nuevos inhibidores de la histona desacetilasa.
KR100620488B1 (ko) 2004-08-13 2006-09-08 연세대학교 산학협력단 신규한 히스톤 디아세틸라아제 억제제 및 이의 제조방법
EP1824831A2 (de) 2004-12-16 2007-08-29 Takeda San Diego, Inc. Histondeacetylase-inhibitoren
US20100087328A1 (en) * 2005-03-01 2010-04-08 The Regents Of The University Of Michigan Brm expression and related diagnostics
WO2006094068A2 (en) * 2005-03-01 2006-09-08 The Regents Of The University Of Michigan Hdac inhibitors that promote brm expression and brm related diagnostics
US7772238B2 (en) 2005-04-20 2010-08-10 Merck Sharp & Dohme Corp. Benzothiophene hydroxamic acid derivatives
GB0509225D0 (en) 2005-05-05 2005-06-15 Chroma Therapeutics Ltd Inhibitors of enzymatic activity
GB0509223D0 (en) 2005-05-05 2005-06-15 Chroma Therapeutics Ltd Enzyme inhibitors
US7642253B2 (en) 2005-05-11 2010-01-05 Takeda San Diego, Inc. Histone deacetylase inhibitors
EP1904452A2 (de) * 2005-07-14 2008-04-02 Takeda San Diego, Inc. Histondeacetylase-inhibitoren
GB0518237D0 (en) * 2005-09-07 2005-10-19 Angeletti P Ist Richerche Bio Therapeutic compounds
AR057579A1 (es) * 2005-11-23 2007-12-05 Merck & Co Inc Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
US8088804B2 (en) * 2005-12-15 2012-01-03 Pfizer Inc. N-hydroxyamide derivatives possessing antibacterial activity
JP2009525955A (ja) * 2006-01-13 2009-07-16 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
EP1979326B1 (de) 2006-01-19 2012-10-03 Janssen Pharmaceutica N.V. Pyridin- und pyrimidinderivate als inhibitoren von histondeacetylase
GB0603041D0 (en) * 2006-02-15 2006-03-29 Angeletti P Ist Richerche Bio Therapeutic compounds
GB0619753D0 (en) 2006-10-06 2006-11-15 Chroma Therapeutics Ltd Enzyme inhibitors
CN101553475B (zh) 2006-10-30 2013-04-24 色品疗法有限公司 作为组蛋白脱乙酰基酶抑制剂的异羟肟酸
GB0713686D0 (en) 2007-07-13 2007-08-22 Addex Pharmaceuticals Sa New compounds 2
JP2010540630A (ja) * 2007-10-04 2010-12-24 メルク・シャープ・エンド・ドーム・コーポレイション ヒストン脱アセチル化酵素阻害剤としてのｎ−ヒドロキシ−ナフタレンジカルボキサミド及びｎ−ヒドロキシ−ビフェニル−ジカルボキサミド化合物
US9265734B2 (en) 2008-09-03 2016-02-23 Biomarin Pharmaceutical Inc. Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors
GB0903480D0 (en) 2009-02-27 2009-04-08 Chroma Therapeutics Ltd Enzyme Inhibitors
CA2828524C (en) 2011-02-28 2020-01-07 Repligen Corporation Histone deacetylase inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
NZ711585A (en) 2013-03-15 2020-05-29 Biomarin Pharm Inc Hdac inhibitors
EP2826769A1 (de) 2013-07-18 2015-01-21 Institut de Recherche pour le Développement ( IRD) Verbindungen zur Behandlung und/oder Vorbeugung parasitärer Erkrankungen und Verfahren zu deren Herstellung
KR101536050B1 (ko) * 2013-07-30 2015-07-13 충북대학교 산학협력단 신규 이사틴 기반 히드록삼산 및 이를 유효성분으로 포함하는 항암용 조성물
WO2015058106A1 (en) * 2013-10-18 2015-04-23 The General Hospital Corporation Imaging histone deacetylases with a radiotracer using positron emission tomography
ES2694053T3 (es) * 2014-03-12 2018-12-17 Chong Kun Dang Pharmaceutical Corp. Compuestos novedosos como inhibidores de histona desacetilasa 6 y composiciones farmacéuticas que comprenden los mismos
WO2019185413A1 (en) 2018-03-27 2019-10-03 Basf Se Pesticidal substituted cyclopropyl derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3825554A (en) * 1969-06-13 1974-07-23 Atlantic Richfield Co Method for preparing cyclic nitrile carbonates
JPS54148743A (en) 1978-05-12 1979-11-21 Asahi Chem Ind Co Ltd Production of methoclopramide
US5700811A (en) 1991-10-04 1997-12-23 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and method of use thereof
US5369108A (en) 1991-10-04 1994-11-29 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and methods of use thereof
US6174905B1 (en) 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
AUPO721997A0 (en) 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds
EP1233958B1 (de) 1999-11-23 2011-06-29 MethylGene Inc. Inhibitoren für histone-deacetylase

Also Published As

Publication number Publication date
AU2002355626B2 (en) 2008-09-25
MA27041A1 (fr) 2004-12-20
DE60215652T2 (de) 2007-08-23
US6784173B2 (en) 2004-08-31
KR100910958B1 (ko) 2009-08-05
MXPA03011501A (es) 2004-03-09
WO2003011851A2 (en) 2003-02-13
AR036055A1 (es) 2004-08-04
PL366729A1 (en) 2005-02-07
BG108450A (en) 2005-01-31
PA8548001A1 (es) 2003-01-24
IL159097A0 (en) 2004-05-12
NO20035555D0 (no) 2003-12-12
SK172004A3 (en) 2004-07-07
DE60215652D1 (de) 2006-12-07
JP2005502641A (ja) 2005-01-27
EP1401824B1 (de) 2006-10-25
RU2003137578A (ru) 2005-05-20
CN1271066C (zh) 2006-08-23
EP1401824A2 (de) 2004-03-31
KR20090059172A (ko) 2009-06-10
RS98203A (en) 2007-02-05
RU2289580C2 (ru) 2006-12-20
PE20030086A1 (es) 2003-02-08
ZA200309260B (en) 2005-02-28
HUP0401233A3 (en) 2007-05-29
GT200200121A (es) 2003-06-19
US20030013757A1 (en) 2003-01-16
CN1516697A (zh) 2004-07-28
ECSP034896A (es) 2004-01-28
US20040214862A1 (en) 2004-10-28
CZ200425A3 (cs) 2004-04-14
HRP20031019A2 (en) 2005-08-31
BR0210424A (pt) 2004-08-17
HK1065787A1 (en) 2005-03-04
HUP0401233A2 (hu) 2004-10-28
CA2449804A1 (en) 2003-02-13
KR20040018270A (ko) 2004-03-02
ES2272800T3 (es) 2007-05-01
JP4195377B2 (ja) 2008-12-10
CO5540280A2 (es) 2005-07-29
NZ529874A (en) 2004-12-24
WO2003011851A3 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
ATE343569T1 (de) Aromatische hydroxamsäurederivate, die sich als hdac inhibitoren eignen
ATE447565T1 (de) Spiro-hydantoin-verbindungen, die sich als entzündungshemmende mittel eignen
NO20040933L (no) Nye gamma-sekretaseinhibitorer.
ATE308544T1 (de) N-substituiete heteroaryloxy-aryl-spiro- pyrimidine-2,4,6-trion metalloproteinase inhibitoren
NO20034042D0 (no) Metallproteinase-inhibitorer
CY2014041I2 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
NO20034308D0 (no) Nye tyrokinase-inhibitorer
NO20041293D0 (no) Alkyn-aryl-fosfodiesterase-4-inhibitorer
NO20041075L (no) Ny 1, 2, 4-triazolforbindelse
PT1370553E (pt) Inibidores de rhoquinase
ATE304015T1 (de) Triaryl-oxy-aryl-spiro-pyrimidin-2, 4, 6-trion metalloproteinase inhibitoren
NO20034032D0 (no) Metallproteinase-inhibitorer
NO20034695D0 (no) Nye sammensetninger
DE60218213D1 (de) Pyridyloxyalkancarbonsäureamid-derivate verwendbar als fungizide
DE60217089D1 (de) Lipidsenkende biphenylcarbonsäureamide
ATE308325T1 (de) Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trion derivate als metalloproteinase inhibitoren
NO20042942L (no) Mousse
SE0301854L (sv) Antiigensättningsbehandling
DE60324703D1 (de) Barbitursäure derivaten.
ATE369342T1 (de) 2,5-disubstituierte 3-mercaptopentansaure
NO20025902D0 (no) Nye fenylpiperaziner
FI20011630A0 (fi) Karsintalaitteisto
DE10297356T8 (de) Lewis-Säure-Katalysatorzusammensetzung
ATE297382T1 (de) 3-heterocyclyl propanohydroxamsäure-derivaten als pcp inhibitoren
ES1051328Y (es) Bañera compacta.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1401824

Country of ref document: EP

REN Ceased due to non-payment of the annual fee